Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lipocine Inc LPCN

Healthcare Biotechnology
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 – LPCN

GlobeNewswire July 22, 2016

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Lipocine, Inc.

Business Wire July 21, 2016

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lipocine Inc. Investors and Encourages Investors to Contact the Firm

Business Wire July 21, 2016

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire July 19, 2016

SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors of Important Deadline in Class Action Filed by Firm - LPCN

Business Wire July 18, 2016

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire July 18, 2016

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN)

GlobeNewswire July 11, 2016

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Lipocine Inc. and Reminds Investors With Losses to Contact the Firm

Business Wire July 9, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN

GlobeNewswire July 8, 2016

IMPORTANT NOTICE TO SHAREHOLDERS:  Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Dead

GlobeNewswire July 7, 2016

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Business Wire July 7, 2016

Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Lipocine Inc.

Business Wire July 7, 2016

Lipocine Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire July 7, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers – LPCN

GlobeNewswire July 6, 2016

Robbins Arroyo LLP: Lipocine, Inc. (LPCN) Misled Shareholders According to a Recently Filed Class Action

Business Wire July 6, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm

Business Wire July 6, 2016

INVESTOR ALERT: Investigation of Lipocine Inc. Announced by Law Offices of Howard G. Smith

Business Wire July 6, 2016

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lipocine Inc. - LPCN

GlobeNewswire July 5, 2016

IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Business Wire July 5, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lipocine Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 – LPCN

GlobeNewswire July 5, 2016